门诊冠心病无创检查患者的医疗资源利用:反映日常实践趋势的队列研究
该回顾性数据库分析纳入≥18岁接受门诊无创心脏诊断检查的患者,评估冠心病的评估前后照护路径及医疗资源利用。胸痛是索引就诊的主要原因(54.8%),SPECT为最主要检查方式(40.3%);90天随访中7.3%患者确诊冠心病,其中19.4%重复诊断检查、26.0%接受血运重建、65.6%接受心导管检查,且上述比例随检查方式而异。
要点
- 胸痛是门诊无创冠心病检查最常见原因,占54.8%。
- SPECT是最主要检查方式,占40.3%。
- 90天内7.3%确诊冠心病,其中65.6%接受心导管检查。
核心结论
- 在大样本真实世界数据中,无创检查的使用及医疗资源利用存在明显差异。
- 结果可能有助于优化系统级照护/诊断路径及价值导向的治疗决策。
研究设计与样本
- 非干预性、回顾性、二次数据库分析,纳入年龄≥18岁接受门诊无创心脏诊断检查的患者。
- 主要目标是了解门诊或急诊环境下接受冠心病无创检查患者的评估前后照护路径及相关干预。
主要发现
- 索引就诊主要原因依次为胸痛(54.8%)、气短(23.7%)、心肌梗死/冠心病/充血性心力衰竭(3.8%)及其他(46.8%)。
- 3.0%患者在最近45天内无明确检查原因。
- 90天随访中7.3%(n=22,083)患者确诊冠心病。
- 确诊冠心病患者中19.4%重复诊断检查、26.0%接受血运重建、65.6%接受心导管检查,且比例随检查方式而异。
关键数值与推荐
- SPECT为最主要诊断检查方式,占40.3%。
临床怎么用
- 可利用上述真实世界资源利用数据评估和优化门诊冠心病无创诊断路径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate, early diagnosis and the initiation of appropriate treatment is central to reducing the clinical burden of coronary artery disease (CAD); however, real-world evidence characterizing healthcare resource utilization (HCRU) associated with testing for CAD is lacking. METHODS AND RESULTS: Using a non-interventional, retrospective, secondary database analysis, patients aged ≥18 years who underwent outpatient non-invasive cardiac diagnostic testing were identified. The primary objective was to gain an understanding of pre- and post-assessment care pathways and the associated interventions for patients who underwent non-invasive testing for CAD in either an outpatient or emergency department setting. Overall, chest pain was the primary reason for the index visit (54.8%), followed by shortness of breath (23.7%), myocardial infarction (MI), coronary artery disease (CAD) or congestive heart failure (CHF) (3.8%), and other (46.8%); 3.0% of patients had no apparent reason for testing in the last 45 days. Single-photon emission computed tomography (SPECT) was the dominant diagnostic testing modality (40.3%). During the 90-day follow-up, 7.3% (n = 22,083) of patients were diagnosed with CAD; among these patients, 19.4% had repeat diagnostic testing, 26.0% of patients had a revascularization procedure, and 65.6% underwent cardiac catheterization. These rates varied by testing modality. CONCLUSIONS: In this study of a large real-world data sample, variability in the use of non-invasive tests and HCRU were evident. These results may assist efforts to optimize system-wide care/diagnostic pathways and value-based treatment decisions for patients.
引用
- Ananthasubramaniam K, Kitt TM, Saxena A, et al. Healthcare resource utilization among patients receiving non-invasive testing for coronary artery disease in an outpatient setting: A cohort study reflecting daily practice trends. J Nucl Cardiol. 2021. PMID: 33660216. doi:10.1007/s12350-021-02549-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。